Please assess the completion status of the following clinical trial:

Trial Title: Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age greater than 18 years~* Positive SARS-CoV-2 testing or consistent clinical syndrome (based on clinical picture e.g. characteristic infiltrates on chest x-ray, laboratory findings, and with agreement by two physicians) in patients under investigation (PUIs).~* Onset of symptoms \< 7 days from date of enrollment~* Oxygen saturation of \>94% on room air with defined risk factors (Table 1) consistent with moderate disease OR oxygen saturation of \< 94% on room air consistent with severe disease~* Ability and willingness to comply with study procedures~Exclusion Criteria:~* QTc greater than 450 milliseconds on screening EKG~* Pregnant or lactating women~* Inability to take oral pills or inability to use a feeding tube~* Inability to obtain informed consent either from the patient or from the next of kin if patient is incapacitated. For the purpose of this study obtaining a verbal consent from a family member on the phone with a witness will be considered acceptable since there is a 'no visitor' policy in force at hospitals.~* Patients requiring ICU level care~* use of azithromycin or hydroxychloroquine within 30 days prior to admission

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Arm A (Type: NO_INTERVENTION): Supportive Care only
- Arm B (Type: EXPERIMENTAL): Hydroxychloroquine 400 mg po bid on Day 1 Hydroxychloroquine 200 mg po bid Days 2 through 5
- Arm C (Type: EXPERIMENTAL): Hydroxychloroquine as in Arm B AND Azithromycin 500 mg po on Day 1 Azithromycin 250 mg po days 2 through 5

Based on this trial design, predict the completion outcome and termination type (if applicable).